RecruitingNCT05204017

Comprehensive Analysis Platform To Understand, Remedy and Eliminate ALS

Studying Amyotrophic lateral sclerosis

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
University of Alberta
Principal Investigator
Sanjay Kalra, MD
University of Alberta
Enrollment
150 enrolled
Eligibility
18 years · All sexes
Timeline
20212025

Study locations (4)

Collaborators

McGill University · Laval University · University of Toronto · Simon Fraser University

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT05204017 on ClinicalTrials.gov

Other trials for Amyotrophic lateral sclerosis

Additional recruiting or active studies for the same condition.

See all trials for Amyotrophic lateral sclerosis

← Back to all trials